Company Profile

Profile last edited on: 4/17/18      CAGE: 7KYP8      UEI: QYGFJDQ518D4

Business Identifier: Human polyclonal antibodies for use in diagnostics, testing, immunotherapeutics and personalized medicine
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

50 West Broadway 3rd Floor
Salt Lake City, UT 84101
   (801) 810-2454
Location: Single
Congr. District: 02
County: Salt Lake

Public Profile

With close ties to University of Utah, SAB Capra, LLC is a privately-held, emerging bioscience company using transgenic goats to produce human polyclonal antibodies for use in diagnostics and testing, targeted immunotherapies and personalized medicine applications. With the initial work in the firm supported by the Utah Science Technology and Research (USTAR) Initiative, a technology based economic development initiative funded by the state of Utah, the company is a wholly owned subsidiary of SAB Biotherapeutics, Inc., which is pioneering the development and use of large transgenic animals for the production of targeted human polyclonal antibodies with their novel DiverstAb™ immunotherapy platform

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Eddie Sullivan -- President & Chief Executive Officer Co-Founder

  Christoph L Bausch -- Chief Science Officer

  Hua Wu -- Senior Scientist / VP Vaccine & Antibody Development

Company News

There are no news available.